Figure 5.
TGF-β1 might have important roles in the inter-conversion and homoeostasis between NSCCs and CSCs via activating EMT. (A) Exogenous supplement of TGF-β1 accelerates transition of CSCs from NSCCs (mean±s.d., n=3; *P=0.02982), whereas SB431542 inhibits the transition (mean±s.d., n=3; *P=0.02395); TGF-β1- and SB431542-treated unsorted SW620 cells showed a significant difference in CSC proportion (mean±s.d., I=3; *P=0.03757). (B) Expressions of E-cadherin in purified NSCCs with or without TGF-β1 and SB431542. (C) Expressions of Vimentin in purified NSCCs with or without TGF-β1 and SB43154. Data was detected through FACS at day 8 post inoculation.